PBE vs. FBIOX
Compare and contrast key facts about Invesco Dynamic Biotechnology & Genome ETF (PBE) and Fidelity Select Biotechnology Portfolio (FBIOX).
PBE is a passively managed fund by Invesco that tracks the performance of the Dynamic Biotech & Genome Intellidex Index (AMEX). It was launched on Jun 23, 2005. FBIOX is managed by Fidelity. It was launched on Dec 16, 1985.
Performance
PBE vs. FBIOX - Performance Comparison
Loading graphics...
PBE vs. FBIOX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | -3.51% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
FBIOX Fidelity Select Biotechnology Portfolio | -3.22% | 36.38% | 7.26% | 10.09% | -15.87% | -12.26% | 38.62% | 36.12% | -10.92% | 27.87% |
Returns By Period
In the year-to-date period, PBE achieves a -3.51% return, which is significantly lower than FBIOX's -3.22% return. Over the past 10 years, PBE has underperformed FBIOX with an annualized return of 7.52%, while FBIOX has yielded a comparatively higher 9.85% annualized return.
PBE
- 1D
- 3.03%
- 1M
- -3.31%
- YTD
- -3.51%
- 6M
- 14.03%
- 1Y
- 26.26%
- 3Y*
- 8.51%
- 5Y*
- 1.51%
- 10Y*
- 7.52%
FBIOX
- 1D
- 0.08%
- 1M
- -6.89%
- YTD
- -3.22%
- 6M
- 11.54%
- 1Y
- 33.83%
- 3Y*
- 17.53%
- 5Y*
- 3.77%
- 10Y*
- 9.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PBE vs. FBIOX - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is lower than FBIOX's 0.69% expense ratio.
Return for Risk
PBE vs. FBIOX — Risk / Return Rank
PBE
FBIOX
PBE vs. FBIOX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PBE | FBIOX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.16 | 1.35 | -0.18 |
Sortino ratioReturn per unit of downside risk | 1.73 | 1.84 | -0.11 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.24 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 2.12 | 2.10 | +0.02 |
Martin ratioReturn relative to average drawdown | 6.21 | 7.73 | -1.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PBE | FBIOX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | 1.35 | -0.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.07 | 0.15 | -0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.30 | 0.37 | -0.08 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.47 | -0.15 |
Correlation
The correlation between PBE and FBIOX is 0.90, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PBE vs. FBIOX - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.09%, less than FBIOX's 2.55% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.09% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
FBIOX Fidelity Select Biotechnology Portfolio | 2.55% | 2.47% | 1.21% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% |
Drawdowns
PBE vs. FBIOX - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for PBE and FBIOX.
Loading graphics...
Drawdown Indicators
| PBE | FBIOX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -71.98% | +26.29% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -12.27% | +0.54% |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | -44.87% | +10.16% |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | -48.66% | +10.82% |
Current DrawdownCurrent decline from peak | -7.54% | -7.32% | -0.22% |
Average DrawdownAverage peak-to-trough decline | -16.33% | -23.72% | +7.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.01% | 4.05% | -0.04% |
Volatility
PBE vs. FBIOX - Volatility Comparison
Invesco Dynamic Biotechnology & Genome ETF (PBE) and Fidelity Select Biotechnology Portfolio (FBIOX) have volatilities of 7.57% and 7.30%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PBE | FBIOX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.57% | 7.30% | +0.27% |
Volatility (6M)Calculated over the trailing 6-month period | 13.75% | 14.68% | -0.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.72% | 23.91% | -1.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.70% | 24.85% | -2.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.15% | 26.38% | -1.23% |